• Keine Ergebnisse gefunden

Short- term costs of conventional vs laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial)

N/A
N/A
Protected

Academic year: 2022

Aktie "Short- term costs of conventional vs laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial)"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Literatur

1. Braga M., Frasson M.,Vignali A., Zuliani W., Civelli V., Di Carlo V.

Laparoscopic v.s. Open Colectomy in Cancer Patients: Long-Term

Complications, Quality of Life, and Survival. Dis Colon Rectum 2005; 48:2217- 2223

2. Franks PJ., Bosanquet N.,Thorpe H., Brown JM., Copeland J., Smith AMH, Quirke P. and Guillou PJ. on behalf of the CLASICC trial participants. Short- term costs of conventional vs laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial). British Journal of Cancer (2006) 95, 6- 12

3. Abraham N.S., Young J.M. and Solomon M.J.. Meta-analysis of short-term outcomes after laparoscopic resection for colorectal cancer. British Journal of Surgery 2004; 91:1111-1124

4. Leung Ka Lau, Samuel PY Kwok, Steve CW Lam, Janet FY Lee, Raymond Y C Yiu, Simon S M Ng, Paul B S Lai, Wan Lee Lau. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 2004: 363:

1187-92

5. The Colon cancer Laparoscopic or Open Resection Study Group.

Laparoscopic surgery versus open surgery for colon cancer: a short-term outcomes of a randomised trial. Lancet Oncol 2005; 6: 477-84

6. Guillou P.J. Quirke Philip, Thorpe Helen, Walker J., Jayne D. G., Smith A.M.Heath R.M. Brown J.M., for the MRC CLASSIC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365: 1718-26

7. Lacy A.M., Garcia.-Valdecasas J.C. , Delgado S., Castells A., Taurá P., Piqué J.M., Visa J. Laparoscopy-assisted colectomy versus open colektomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002:

359: 2224-29

8. King P.M., Blazeby J.M., Ewings P., Franks P.J., Longman R.J., Kendrick A.H., Kipling R.M., Kennedy R.H. Randomized clinical trial comparing laparoscopic and open surgery for colorectal cancer within an enhanced recovery programme. British Journal of Surgery 2006; 93: 300-308

(2)

9. The Clinical Outcomes of Surgical Therapy Study Group. A Comparison of Laparoscopically Assisted and Open Colectomie for Colon Cancer. N.Engl J Med 2004: 350: 2050-9.

10. Reza M.M., Blasco J.A., Anddradas E., Cantero R., Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. British Journal of Surgery 2006; 93: 921-928

11. Schwandner O., Scheele J., Bruch H.-P. Minimalinvasive Kolonchirurgie:

Welche Vorteile sind evidenzbasiert? Chir. Gastroenterol 2005: 21: 338-346 12. Schwenk W., Haase O., Neudecker J., Müller JM. Short term benefits for

laparoscopic colorectal resection (Review) The Cfochrane Collaboration. The Cochrane Library 2006, Issue 1

13. Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991;1:144-150

/tmp/jodconverter_13e39e5d-deca-42b1-9072-967442874f3b/tempfile_482.doc

Referenzen

ÄHNLICHE DOKUMENTE

Patients were divided into four groups: Group 1—patients without hepatic recurrence after primary liver resection (n = 441); Group 2—patients with liver recurrence who under- went

Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Mc Laughlin VM, Archer

Our cases underline the risk of alcohol intake and malnutrition after laparoscopic bariatric surgery as causes of severe liver decompensation and underline the need for

Methods: The COMICS trial is a multi-centre, international, two-group parallel randomised controlled trial testing whether type II, III or IV minimally invasive

Paclitaxel (175 versus 225 mg/m 2 ) as a 3-h intravenous infusion has been tested in combination with carboplatin (AUC of 6), with slight differences in favour of the higher

A prospective ran- domized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin and cisplatin in advanced epithelial ovarian cancer A Danish Ovarian Study Group

Constrained ordination of first two canonical axes as determined by RDA of yield and yield components (plant density after emergence m −2 , number of tillers m −2 , number of ears m